SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-001223
Filing Date
2018-02-08
Accepted
2018-02-07 17:33:30
Documents
57
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12312017rasna10-qq1.htm 10-Q 621655
2 EXHIBIT 31.1 a12312017rasnaexhibit311.htm EX-31.1 14045
3 EXHIBIT 31.2 a12312017rasnaexhibit312.htm EX-31.2 13486
4 EXHIBIT 32.1 a12312017rasnaexhibit321.htm EX-32.1 5248
5 EXHIBIT 32.2 a12312017rasnaexhibit322.htm EX-32.2 5287
  Complete submission text file 0001628280-18-001223.txt   4007464

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rasp-20171231.xml EX-101.INS 696736
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rasp-20171231.xsd EX-101.SCH 41135
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rasp-20171231_cal.xml EX-101.CAL 41664
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rasp-20171231_def.xml EX-101.DEF 171983
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rasp-20171231_lab.xml EX-101.LAB 502713
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rasp-20171231_pre.xml EX-101.PRE 291305
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0929
Type: 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 18582092
SIC: 2834 Pharmaceutical Preparations